Charles River Laboratories International (CRL) Total Debt Growth (3y) (2012 - 2026)
Charles River Laboratories International (CRL) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 9.22% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -39.51% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.11% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -4.73% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -0.64% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 5.13% |
| 10 | Charles River Laboratories International | 14.28 Bn | 14.09 Bn | 452.07 Mn | -0.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -0.73% |
| Dec 27, 2025 | -7.59% |
| Sep 27, 2025 | -9.40% |
| Jun 28, 2025 | -8.04% |
| Mar 29, 2025 | -2.14% |
| Dec 28, 2024 | -5.64% |
| Sep 28, 2024 | -7.03% |
| Jun 29, 2024 | -4.08% |
| Mar 30, 2024 | 6.45% |
| Dec 30, 2023 | 10.17% |
| Jul 1, 2023 | 5.81% |
| Apr 1, 2023 | 4.94% |
| Dec 31, 2022 | 12.76% |
| Sep 24, 2022 | 15.33% |
| Jun 25, 2022 | 13.08% |
| Mar 26, 2022 | 19.46% |
| Dec 25, 2021 | 16.92% |
| Sep 25, 2021 | 19.78% |
| Jun 26, 2021 | 14.31% |
| Mar 27, 2021 | 24.87% |